The US FDA added bemotrizinol, under the trademark PARSOL® Shield by dsm-firmenich, to the list of permitted sunscreen active ingredients—marking the first new UV filter added to the OTC monograph since the late 1990s. It is a remarkable milestone as skin cancer is truly on the rise in the US.

In this episode of The Happi Podcast, we speak with Parand Salmassinia, president of Beauty & Care, dsm-firmenich, about this major milestone for the industry and what comes next.

In this Happi podcast, you will hear about:

• The impact of Bemotrizinol, PARSOL® Shield, and its approval by the US FDA as a UV filter in the US.
• How dsm-firmenich advocated for the safety and science of BEMT.
• Benefits that this filter will bring to the US suncare industry, from formulators to consumers.
• Scientific substantiation: an extensive study conducted with diverse skin types.
• When the first products with PARSOL® Shield are expected to hit the market in the US.
• dsm-firmenich’s commitment to skin cancer prevention and public health.

For more on PARSOL® Shield, see the August issue of Happi, and visit the dsm-firmenich website.